“Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association” was published today. The statement provides a thorough examination of statin safety and tolerability based on the highest quality evidence available. Associate Professor David Preiss was a lead member of the Writing Group for the committee.
Statin safety
10 December 2018
Latest news
New open-source tool helps researchers test robustness of findings
14 August 2026
Oxford researchers launch RobustiPy, a new open-source tool designed to ensure research is robust and reliable.
Post-pandemic increase in alcohol-related liver disease deaths was greatest outside hospital
12 August 2026
Study finds alcohol-related liver disease deaths rose sharply after the pandemic, particularly among people with no recent hospital care.
Statins reduce hospital admissions but increase overall healthcare use
11 August 2026
Study finds statins reduce healthcare use initially, but longer lives mean greater overall demand for health services over time